Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tian-yu Song"'
Autor:
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, Su Wang, Daisuke Ogiya, Tian-Yu Song, Keiji Kurata, Johany Penailillo, Eugenio Morelli, Tingjian Wang, Xiaoning Hong, Annamaria Gulla, Yu-Tzu Tai, Nikhil Munshi, Paul Richardson, Ruben Carrasco, Teru Hideshima, Kenneth C. Anderson
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Anti-CD38 monoclonal antibodies like Daratumumab (Dara) are effective in multiple myeloma (MM); however, drug resistance ultimately occurs and the mechanisms behind this are poorly understood. Here, we identify, via two in vitro genome-wide
Externí odkaz:
https://doaj.org/article/7f2fe4cc076c4f8aab09d7ab7cfd3475
Autor:
Tian-Yu Song, Min Long, Hai-Xin Zhao, Miao-Wen Zou, Hong-Jie Fan, Yang Liu, Chen-Lu Geng, Min-Fang Song, Yu-Feng Liu, Jun-Yi Chen, Yu-Lin Yang, Wen-Rong Zhou, Da-Wei Huang, Bo Peng, Zhen-Gang Peng, Yong Cang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Dysregulation of the microRNA machinery has crucial roles in cancer development. Here the authors show that inactivation of proteins involved in microRNA-mediated gene silencing, such as ANKRD52 or AGO2, confers resistance to T cell-mediated immune r
Externí odkaz:
https://doaj.org/article/6892ee3856f549c5b325b419289c5910
Autor:
Shuang, Zhao, Tian-Yu, Song, Zi-Yu, Wang, Jie, Gao, Jia-Wei, Cao, Lu-Lu, Hu, Zheng-Rong, Huang, Li-Ping, Xie, Yong, Ji
Publikováno v:
Acta Pharmacologica Sinica. 43:1979-1988
Cardiac hypertrophy, as one of the major predisposing factors for chronic heart failure, lacks effective interventions. Exploring the pathogenesis of cardiac hypertrophy will reveal potential therapeutic targets. S-nitrosylation is a kind of posttran
Autor:
Min-Fang Song, Wenrong Zhou, Yu-Feng Liu, Yu-Lin Yang, Yang Liu, Jun-Yi Chen, Hong-Jie Fan, Min Long, Dawei Huang, Bo Peng, Yong Cang, Chen-Lu Geng, Zhengang Peng, Haixin Zhao, Tian-yu Song, Miao-Wen Zou
Publikováno v:
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Cancer cells acquire genetic heterogeneity to escape from immune surveillance during tumor evolution, but a systematic approach to distinguish driver from passenger mutations is lacking. Here we investigate the impact of different immune pressure on
Publikováno v:
Chinese Journal of Chemical Physics. 31:677-683
A novel water-soluble luminescent complex consisting of Eu(ally-dbm)3-2Tppo and poly(N-isopropyl acrylamide) (PNIPAM) is synthesized through a series of chemical reactions. The structure of the complex is characterized by TGA, GPC, HNMR, and the ther
Autor:
Dawei Huang, Yang Liu, Hong-Jie Fan, Yong Cang, Xiaoxiao Xie, Min Long, Bo Peng, Chen-Lu Geng, Zhengang Peng, Tian-yu Song, Haixin Zhao
Publikováno v:
Cancer Research. 81:3140-3140
Cancer arises after somatic mutations override cellular and immunological control of cell proliferation1. Mutations in oncogenes and tumor suppressor genes endow cancer cells intrinsic growth advantage over neighboring cells. Mutations can also enabl
Publikováno v:
Cancer Research. 81:1600-1600
Cancer mutations play essential roles in tumor development by promote cell proliferation or immune evasion. However, some recent researches indicate that cancer cells with these mutation burden also expose their vulnerability to immune-based therapie
Publikováno v:
Journal of Dalian University of Technology / Dalian Ligong Daxue Xuebao; 2009, Vol. 49 Issue 2, p276-281, 6p